Nephropathy - DiabetesontheNet

This site is intended for healthcare professionals only

Nephropathy

Filter:

Testing for kidney disease in type 2 diabetes: consensus statement and recommendations

Screening and testing for diabetic kidney disease: guidance for clinical practice.

5 Oct 2020

ADA from home!

Practical messages for primary care practice from the American Diabetes Association's annual conference.

15 Jul 2020

News from the 2020 ADA conference

Breaking news stories from a primary care perspective.

1 Jul 2020

DAPA-CKD trial: Phase 3 stopped early after showing efficacy for CKD

AstraZeneca has announced that the phase 3 DAPA-CKD (Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease) trial will be stopped early following a recommendation from an independent data monitoring committee (DMC) based on its determination of overwhelming efficacy

30 Mar 2020

The management of hyperglycaemia in people with diabetes and chronic kidney disease: A GPnotebook Shortcut

Glucose-lowering drug indications and dosing recommendations: a GPnotebook quick guide.

28 Jan 2020

GLP-1 receptor agonists significantly improve CV outcomes

12 Dec 2019

GLP-1 receptor agonists have a wide range of benefits

12 Dec 2019

Q&A: Diabetes and kidney disease. Part 2: management

Management of diabetic kidney disease: questions from primary care answered.

29 Oct 2019

Diabetes Distilled: Retinopathy differentiates nephropathy type but not severity in diabetes

Retinopathy is helpful in diagnosing diabetic nephropathy in type 2 diabetes.

29 Oct 2019

Q&A: Diabetes and kidney disease. Part 1: diagnosis

Diagnosis of diabetic kidney disease: questions from primary care answered.

8 Oct 2019

Renoprotection for patients with diabetes and kidney disease

4 Oct 2019

Canagliflozin is cardioprotective in diabetic kidney disease

4 Oct 2019

Updates from the 2019 ADA meeting

News of the most important trial results for diabetes care from the 79^th Scientific Sessions of the American Diabetes Association.

6 Aug 2019

Renal trials, sex disparities in treatment, amputation and ADA nutrition guidelines

A round-up of the latest evidence and developments that will influence diabetes care.

7 May 2019

Higher BMI predicts major renal events in people with T2D

28 Mar 2018

Studies that changed clinical practice. The MICRO-HOPE Study: Evidence for an important role for ACE inhibitors

A summary of the outcomes of this landmark study and outlines its relevance to current clinical practice.

8 Mar 2018

Metformin treatment in people with T2D and chronic kidney disease

Metformin is the first-line drug of choice in the treatment of type 2 diabetes in most diabetes guidance. Last year the European Medicines Agency (EMA) altered the restrictions on metformin use in people with diabetes and researchers wanted to discover, in the absence of prospective safety and efficacy studies, what was a safe, effective dose regimen for metformin in moderate and severe chronic kidney disease (CKD). Investigators concluded that metformin appeared to be safe, provided that there was dose adjustment for renal function. It was also found to be efficacious in moderate-to-severe CKD.

22 Feb 2018

Comorbidities in the diabetic patient with foot problems

6 Nov 2017

Resources

For the latest news and articles

Resources

Journals

Useful information

;